68
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Antioxidant, Cytotoxic and Anti-choline Esterase Activity of Green Silver Nanoparticles Synthesized Using Aspergillus austroafricanus CGJ-B3 (Endophytic Fungus)

, , , , , & show all
Pages 15-28 | Received 05 Oct 2020, Accepted 23 Jan 2021, Published online: 24 Feb 2021
 

Abstract

Despite the use of a vast number of natural products in the synthesis of nanoparticles, many microorganisms, such as endophytic fungi, are still largely unexplored. In the present study, silver nanoparticles (AgNPs) were synthesized using the endophytic fungus Aspergillus austroafricanus CGJ-B3. AgNPs were characterized by UV-Visible spectroscopy (UV-Vis), Transmission electron microscopy (TEM), selected area electron diffraction (SAED), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and Energy dispersive X-ray (EDX). Antioxidant, cytotoxic, and anti-choline esterase activities were assessed using 1, 1-Diphenyl-2-picryl-hydrazyl (DPPH), 2, 3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5- Carboxanilide (XTT), and microplate method respectively. AgNPs were spherical in shape and their sizes ranged from 2.00 to 51.34 nm. They showed significant antioxidant, cytotoxic and anti-choline esterase activity. Interestingly, AgNPs displayed substantial cytotoxic activity against cancer (MCF-7, A431, and HepG2) cell lines than noncancerous (HEK-293) cells. The results highlight their possible use of novel therapeutic agents against cancer and Alzheimer’s disease.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.